|
2022 Journal Article The duodenal mucosa associated microbiome, visceral sensory function, immune activation and psychological comorbidities in functional gastrointestinal disorders with and without self-reported non-celiac wheat sensitivityShah, Ayesha, Kang, Seungha, Talley, Nicholas J., Do, Anh, Walker, Marjorie M., Shanahan, Erin R., Koloski, Natasha A., Jones, Michael P., Keely, Simon, Morrison, Mark and Holtmann, Gerald J. (2022). The duodenal mucosa associated microbiome, visceral sensory function, immune activation and psychological comorbidities in functional gastrointestinal disorders with and without self-reported non-celiac wheat sensitivity. Gut Microbes, 14 (1) 2132078, 1-21. doi: 10.1080/19490976.2022.2132078 |
|
2022 Journal Article Diabetes mellitus is an independent risk factor for a greater frequency of early satiation and diarrhea at one and three years: two prospective longitudinal population‐based studiesKoloski, Natasha A., Jones, Michael, Walker, Marjorie M., Horowitz, Michael, Holtmann, Gerald and Talley, Nicholas J. (2022). Diabetes mellitus is an independent risk factor for a greater frequency of early satiation and diarrhea at one and three years: two prospective longitudinal population‐based studies. Neurogastroenterology and Motility, 35 (1) e14471, 1-11. doi: 10.1111/nmo.14471 |
|
2022 Journal Article How frequent are vancomycin-resistant enterococci in patients with primary sclerosing cholangitis and ulcerative colitis treated with oral vancomycin?Shah, Ayesha, Pakneeshan, Sahar, Jones, Michael P., Koloski, Natasha, Callaghan, Gavin, Morrison, Mark and Holtmann, Gerald (2022). How frequent are vancomycin-resistant enterococci in patients with primary sclerosing cholangitis and ulcerative colitis treated with oral vancomycin?. Indian Journal of Gastroenterology, 41 (5), 519-524. doi: 10.1007/s12664-022-01286-9 |
|
2022 Journal Article Asian-Pacific consensus on small intestinal bacterial overgrowth in gastrointestinal disorders: an initiative of the Indian Neurogastroenterology and Motility AssociationGhoshal, Uday C., Sachdeva, Sanjeev, Ghoshal, Ujjala, Misra, Asha, Puri, Amarender Singh, Pratap, Nitesh, Shah, Ayesha, Rahman, M. Masudur, Gwee, Kok Ann, Tan, Victoria P Y, Ahmed, Tahmeed, Lee, Yeong Yeh, Ramakrishna, B. S., Talukdar, Rupjyoti, Rana, S. V., Sinha, Saroj K, Chen, Minhu, Kim, Nayoung and Holtmann, Gerald (2022). Asian-Pacific consensus on small intestinal bacterial overgrowth in gastrointestinal disorders: an initiative of the Indian Neurogastroenterology and Motility Association. Indian Journal of Gastroenterology, 41 (5), 483-507. doi: 10.1007/s12664-022-01292-x |
|
2022 Conference Publication Diversity of Veillonella in cultures of the duodenal mucosa-associated microbiota suggests species-level differences between people with and without functional gastrointestinal symptomsSchooth, L., Sid-Ahmed, A., Kang, S., Lim, Y., Fairlie, T., Shah, A., Holtmann, G. and Morrison, M. (2022). Diversity of Veillonella in cultures of the duodenal mucosa-associated microbiota suggests species-level differences between people with and without functional gastrointestinal symptoms. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2022, Sydney, NSW Australia, 9–11 September 2022. Richmond, VIC Australia: John Wiley & Sons. |
|
2022 Journal Article Links between celiac disease and small intestinal bacterial overgrowth: A systematic review and meta‐analysisShah, Ayesha, Thite, Parag, Hansen, Teressa, Kendall, Bradley J., Sanders, David S., Morrison, Mark, Jones, Michael P. and Holtmann, Gerald (2022). Links between celiac disease and small intestinal bacterial overgrowth: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology, 37 (10), 1844-1852. doi: 10.1111/jgh.15920 |
|
2022 Journal Article Utilising lipid and, arginine and proline metabolism in blood plasma to differentiate the biochemical expression in functional dyspepsia (FD) and irritable bowel syndrome (IBS)Karpe, Avinash V., Liu, Jian-Wei, Shah, Ayesha, Koloski, Natasha, Holtmann, Gerald and Beale, David J. (2022). Utilising lipid and, arginine and proline metabolism in blood plasma to differentiate the biochemical expression in functional dyspepsia (FD) and irritable bowel syndrome (IBS). Metabolomics, 18 (6) 38, 1-11. doi: 10.1007/s11306-022-01900-z |
|
2022 Journal Article Evidence-based and emerging diet recommendations for small bowel disordersRej, Anupam, Potter, Michael D. E., Talley, Nicholas J., Shah, Ayesha, Holtmann, Gerald and Sanders, David Surendran (2022). Evidence-based and emerging diet recommendations for small bowel disorders. American Journal of Gastroenterology, 117 (6), 958-964. doi: 10.14309/ajg.0000000000001764 |
|
2022 Journal Article Current and future approaches for diagnosing small intestinal dysbiosis in patients with symptoms of functional dyspepsiaShah, Ayesha, Talley, Nicholas J. and Holtmann, Gerald (2022). Current and future approaches for diagnosing small intestinal dysbiosis in patients with symptoms of functional dyspepsia. Frontiers in Neuroscience, 16 830356, 1-12. doi: 10.3389/fnins.2022.830356 |
|
2022 Conference Publication Strain-level functional and phenotypic resolution of the duodenal mucosa-associated microbiota in functional dyspepsia and healthy control subjects via a novel ex vivo combination of microbe culture and metagenomic sequencingSchooth, Lauren F., Ahmed, Ahmed Sid, Kang, Seungha, Shah, Ayesha, Fairlie, Thomas, Teh, Jing Jie, Lim, Yenkai, Hoedt, Emily C., Talley, Nicholas J., Keely, Simon, Holtmann, Gerald J. and Morrison, Mark (2022). Strain-level functional and phenotypic resolution of the duodenal mucosa-associated microbiota in functional dyspepsia and healthy control subjects via a novel ex vivo combination of microbe culture and metagenomic sequencing. American Gastroenterological Association Conference 2022, Chicago, IL United States, 6-9 May 2022. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(22)61208-3 |
|
2022 Conference Publication Influence of proton pump inhibitors on the mucosa associated microbiome in the small intestine and colonShah, Ayesha, Sternes, Peter R., Pintos, Camila Ayala, Kang, Seungha, Jones, Michael P., Tyson, Gene, Morrison, Mark and Holtmann, Gerald J. (2022). Influence of proton pump inhibitors on the mucosa associated microbiome in the small intestine and colon. American Gastroenterological Association Conference 2022, Chicago, IL United States, 6-9 May 2022. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(22)62401-6 |
|
2022 Journal Article Letter: non‐invasive transabdominal stimulation device for the treatment of chronic constipation—proof‐of‐principle study in adultsTalley, Nicholas J., Holtmann, Gerald J., Southwell, Bridget R., Fisher, David, Koloski, Natasha A. and Jones, Michael (2022). Letter: non‐invasive transabdominal stimulation device for the treatment of chronic constipation—proof‐of‐principle study in adults. Alimentary Pharmacology and Therapeutics, 55 (10), 1354-1356. doi: 10.1111/apt.16877 |
|
2022 Journal Article Role of the duodenal microbiota in functional dyspepsiaBrown, Georgia, Hoedt, Emily C., Keely, Simon, Shah, Ayesha, Walker, Marjorie M., Holtmann, Gerald and Talley, Nicholas J. (2022). Role of the duodenal microbiota in functional dyspepsia. Neurogastroenterology and Motility, 34 (11) e14372, e14372. doi: 10.1111/nmo.14372 |
|
2022 Journal Article Evaluation of a multidisciplinary integrated treatment approach versus standard model of care for Functional Gastrointestinal Disorders (FGIDS): a matched cohort studyBray, Nicola A., Koloski, Natasha A., Jones, Michael P., Do, Anh, Pang, Siong, Coombes, Jeff S., McAllister, Sarah, Campos, Jane, Arthur, Leela, Stanley, Paul, DeMaria, Katherine, Chao, Che-yung, Catague, Rachel, Whaley, Amanda, Talley, Nicholas J. and Holtmann, Gerald J. (2022). Evaluation of a multidisciplinary integrated treatment approach versus standard model of care for Functional Gastrointestinal Disorders (FGIDS): a matched cohort study. Digestive Diseases and Sciences, 67 (12), 1-9. doi: 10.1007/s10620-022-07464-1 |
|
2022 Journal Article Overlap of heartburn, functional dyspepsia, and irritable bowel syndrome in a population sample: prevalence, temporal stability, and associated comorbiditiesJones, Michael P., Shah, Ayesha, Walker, Marjorie M., Koloski, Natasha A., Holtmann, Gerald and Talley, Nicholas J. (2022). Overlap of heartburn, functional dyspepsia, and irritable bowel syndrome in a population sample: prevalence, temporal stability, and associated comorbidities. Neurogastroenterology and Motility, 34 (9) e14349, e14349. doi: 10.1111/nmo.14349 |
|
2022 Journal Article Defects in NLRP6, autophagy and goblet cell homeostasis are associated with reduced duodenal CRH receptor 2 expression in patients with functional dyspepsiaBruce, Jessica K., Burns, Grace L., Sinn Soh, Wai, Nair, Prema M., Sherwin, Simonne, Fan, KeNing, Dowling, Laura R., Goggins, Bridie J., Koloski, Natasha, Potter, Michael, Bollipo, Steven, Foster, Robert, Gan, Lay T., Veysey, Martin, Philpott, Dana J., Girardin, Stephen E., Holtmann, Gerald, Kaiko, Gerard E., Walker, Marjorie M., Talley, Nicholas J. and Keely, Simon (2022). Defects in NLRP6, autophagy and goblet cell homeostasis are associated with reduced duodenal CRH receptor 2 expression in patients with functional dyspepsia. Brain, Behavior, and Immunity, 101, 335-345. doi: 10.1016/j.bbi.2022.01.019 |
|
2022 Journal Article Duodenal eosinophils and mast cells in functional dyspepsia: a systematic review and meta-analysis of case-control studiesShah, Ayesha, Fairlie, Thomas, Brown, Georgia, Jones, Michael P., Eslick, Guy D., Duncanson, Kerith, Thapar, Nikhil, Keely, Simon, Koloski, Natasha, Shahi, Mohit, Walker, Marjorie M., Talley, Nicholas J. and Holtmann, Gerald (2022). Duodenal eosinophils and mast cells in functional dyspepsia: a systematic review and meta-analysis of case-control studies. Clinical Gastroenterology and Hepatology, 20 (10), 2229-2242.e29. doi: 10.1016/j.cgh.2022.01.014 |
|
2022 Journal Article Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trialPeyrin-Biroulet, Laurent, Hart, Ailsa, Bossuyt, Peter, Long, Millie, Allez, Matthieu, Juillerat, Pascal, Armuzzi, Alessandro, Loftus, Edward V, Ostad-Saffari, Elham, Scalori, Astrid, Oh, Young S, Tole, Swati, Chai, Akiko, Pulley, Jennifer, Lacey, Stuart, Sandborn, William J, Aguilar, Humberto, Ahmad, Tariq, Akriviadis, Evangelos, Aldeguer Mante, Xavier, Altorjay, Istvan, Ananthakrishnan, Ashwin, Andersen, Vibeke, Andreu Garcia, Montserrat, Aumais, Guy, Avni-Biron, Irit, Axler, Jeffrey, Ayub, Kamran, Baert, Filip ... Zeuzem, Stefan (2022). Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial. The Lancet Gastroenterology and Hepatology, 7 (2), 128-140. doi: 10.1016/S2468-1253(21)00298-3 |
|
2022 Journal Article Updated S3 guideline on intestinal motility disorders: Definition, pathophysiology, diagnosis and treatment. Joint guideline of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS) and the German Society for Neurogastroenterology and Motility (DGNM). June 2021 - AWMF Register No.: 021-018 Update S3-Leitlinie Intestinale Motilitätsstörungen: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM)Keller, Jutta, Wedel, Thilo, Seidl, Holger, Kreis, Martin E., Van Der Voort, Ivo, Gebhard, Maximilian, Langhorst, Jost, Lynen Jansen, Petra, Schwandner, Oliver, Storr, Martin, Van Leeuwen, Pia, Andresen, Viola, Preiβ, Jan C., Layer, Peter, Allescher, H., Andus, T., Bischoff, S. C., Buderus, S., Claβen, M., Ehlert, U., Elsenbruch, S., Engel, M., Enninger, A., Fischbach, W., Freitag, M., Frieling, T., Gillessen, A., Goebel-Stengel, M., Gschossmann, J. ... Von Schönfeld, J. (2022). Updated S3 guideline on intestinal motility disorders: Definition, pathophysiology, diagnosis and treatment. Joint guideline of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS) and the German Society for Neurogastroenterology and Motility (DGNM). June 2021 - AWMF Register No.: 021-018 Update S3-Leitlinie Intestinale Motilitätsstörungen: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM). Zeitschrift fur Gastroenterologie, 60 (2), 192-218. doi: 10.1055/a-1646-1279 |
|
2022 Journal Article Small intestinal bacterial overgrowth in inflammatory bowel diseaseShah, Ayesha and Holtmann, Gerald (2022). Small intestinal bacterial overgrowth in inflammatory bowel disease. Indian Journal of Gastroenterology, 41 (1), 23-29. doi: 10.1007/s12664-021-01235-y |
